TP53 and lung carcinoma: A previous study suggests that GMFG expression is downregulated in LUAD tissues compared to normal lung tissues and that it may exert anti-cancer effects by activating the p53 signaling pathway, thereby inhibiting the progression of lung cancer (Tang et al. 2022).